Trade Report: Today, Mason Street Advisors LLC Takes Position in Aceto Corp. (ACET)

Today, Mason Street Advisors LLC Takes Position in Aceto Corp. (ACET)

Mason Street Advisors LLC acquired a new stake in Aceto Corp. (NASDAQ:ACET) during the second quarter, Holdings Channel reports. The institutional investor acquired 5,784 shares of the company’s stock, valued at approximately $127,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Rational Advisors LLC bought a new position in shares of Aceto Corp. during the second quarter valued at about $125,000. Bessemer Group Inc. bought a new position in shares of Aceto Corp. during the first quarter valued at about $159,000. BNP Paribas Arbitrage SA increased its position in shares of Aceto Corp. by 115.2% in the second quarter. BNP Paribas Arbitrage SA now owns 9,442 shares of the company’s stock valued at $207,000 after buying an additional 5,055 shares in the last quarter. Parametric Portfolio Associates LLC increased its position in shares of Aceto Corp. by 4.7% in the second quarter. Parametric Portfolio Associates LLC now owns 10,481 shares of the company’s stock valued at $229,000 after buying an additional 473 shares in the last quarter. Finally, Barclays PLC increased its position in shares of Aceto Corp. by 14,700.0% in the second quarter. Barclays PLC now owns 11,100 shares of the company’s stock valued at $243,000 after buying an additional 11,025 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Shares of Aceto Corp. (NASDAQ:ACET) opened at 19.16 on Monday. The firm has a 50-day moving average of $19.31 and a 200 day moving average of $22.32. Aceto Corp. has a 1-year low of $18.25 and a 1-year high of $32.20. The stock has a market capitalization of $568.06 million, a PE ratio of 16.24 and a beta of 1.50.

Aceto Corp. (NASDAQ:ACET) last posted its quarterly earnings data on Thursday, August 25th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by $0.04. The company earned $135.40 million during the quarter, compared to the consensus estimate of $146.71 million. Aceto Corp. had a net margin of 6.22% and a return on equity of 15.39%. The company’s revenue was down 7.6% on a year-over-year basis. During the same quarter last year, the business earned $0.40 earnings per share. On average, equities analysts anticipate that Aceto Corp. will post $1.50 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a $0.065 dividend. The ex-dividend date was Wednesday, September 7th. This is a boost from Aceto Corp.’s previous quarterly dividend of $0.06. This represents a $0.26 annualized dividend and a dividend yield of 1.36%. Aceto Corp.’s dividend payout ratio (DPR) is 22.03%.

Several research analysts recently issued reports on the company. Craig Hallum restated a “buy” rating on shares of Aceto Corp. in a research report on Monday, August 29th. Zacks Investment Research raised shares of Aceto Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, August 2nd.

In related news, Chairman Albert L. Eilender sold 12,936 shares of the stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $19.92, for a total transaction of $257,685.12. Following the completion of the sale, the chairman now directly owns 236,649 shares of the company’s stock, valued at $4,714,048.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Steven Rogers sold 2,167 shares of the stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $20.04, for a total transaction of $43,426.68. Following the sale, the senior vice president now directly owns 20,443 shares of the company’s stock, valued at $409,677.72. The disclosure for this sale can be found here. 3.70% of the stock is currently owned by insiders.

Aceto Corp. Company Profile

Aceto Corporation (Aceto) is engaged in marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.

Related posts

Leave a Comment